Table 2.
Distribution of involvement sites in EPTB cases
| Involved area | n | % |
|---|---|---|
| Lymph nodes | 45 | 12.0 |
| Cervical | 38 | 9.2 |
| Inguinal | 2 | 0.5 |
| Mediastinum | 1 | 0.2 |
| Axillary | 1 | 0.2 |
| Paratracheal | 1 | 0.2 |
| Mediastinal LAP | 1 | 0.2 |
| Supraclavicular | 1 | 0.2 |
| Pleural | 40 | 10.8 |
| Abdominal | ||
| Peritoneum | 4 | 1.1 |
| Omentum | 2 | 0.5 |
| Intestines | 4 | 1.1 |
| Urogenital | ||
| Kidney | 3 | 0.8 |
| Ovarian tubes | 2 | 0.5 |
| Testicles | 1 | 0.3 |
| Ovary | 2 | 0.5 |
| Osteoarticular | ||
| Vertebra | 7 | 1.9 |
| Spondylodiscitis | 2 | 0.5 |
| Wrist | 1 | 0.3 |
| Skin and soft tissue | ||
| Breast | 11 | 0.3 |
| Skin | 3 | 0.8 |
| Psoas | 3 | 0.8 |
| Nasopharynx | 1 | 0.3 |
| CNS | 7 | 1.9 |
LAP = Lymphadenopathy; CNS = central nervous system.